chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 5.0
Sex: F
Vaccine: FLU3
Symptoms: Immediate post-injection reaction, Injection site discomfort, Injection site erythema, Injection site induration, Injection site pain
Clinical narrative: Mother reports pain and area underneath injection site was hard to the touch immediately afterwards. Child "picked" at the site and expressed discomfort since injection to present. 2 days ago, site acutely became red, swollen and now has developed purulent drainage. Today 1/13/16 will begin oral antibiotic course and warm compress.
Age: 5.0
Sex: F
Vaccine: FLU3
Symptoms: Injection site reaction, Injection site swelling, Purulent discharge
Clinical narrative: Mother reports pain and area underneath injection site was hard to the touch immediately afterwards. Child "picked" at the site and expressed discomfort since injection to present. 2 days ago, site acutely became red, swollen and now has developed purulent drainage. Today 1/13/16 will begin oral antibiotic course and warm compress.
Age: 73.0
Sex: F
Vaccine: PNC13
Symptoms: Pain in extremity
Clinical narrative: Patient called on 12/4/15 stating pain in (L) arm from PREVNAR. As of 1/11/16 patient still reports (L) arm pain.
Age: 4.0
Sex: M
Vaccine: FLUR3
Symptoms: Drug administered to patient of inappropriate age
Clinical narrative: Pt given FLUBLOK vaccine; pt was too young to receive the shot per ACIP and manufacturer's recommendations. Parents contacted and are aware to call if problems arise. (Parents called same day vaccine was given).
Age: 11.0
Sex: M
Vaccine: HPV9, MNQ
Symptoms: Erythema, Peripheral swelling, Skin warm
Clinical narrative: Left arm red, warm and swollen starting 1/12/16, BENADRYL ordered 1/13/16 by provider. Plan to recheck tomorrow.
Age: 4.0
Sex: F
Vaccine: DT
Symptoms: Erythema, Injection site pruritus, Injection site reaction, Swelling, Urticaria
Clinical narrative: Localized erythema, swelling 7 days after vaccination - surrounding site 3" diameter approximately large "hive-like" welt, very itchy.
Age: 63.0
Sex: F
Vaccine: VARZOS
Symptoms: Herpes zoster
Clinical narrative: Patient developed shingles 6 days after immunization. She is being treated with acyclovir for the shingles.
Age: 70.0
Sex: F
Vaccine: FLU3
Symptoms: Diarrhoea, Hypotension, Palpitations
Clinical narrative: Pt reported diarrhea, palpitations and low blood pressure 2 days after vaccine. Was seen at local ER but no diagnosis was made.
Age: 85.0
Sex: M
Vaccine: FLU3
Symptoms: Hypotension, Vomiting
Clinical narrative: Pt reported vomiting and low blood pressure approximately after receiving the flu vaccine. Managed at home.
Sex: U
Vaccine: HPV4
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report received from a registered nurse refers to multiple unspecified patients of unknown demographics. No medical history was reported. On multiple unspecified dates, multiple unspecified patients were vaccinated with improperly stored GARDASIL (dose, route and frequency: unknown) (Lot number: L037003; expiry date: 27-MAY-2017). No other concomitant therapy was reported. No adverse event was reported. The reporter also inquired about the stability of M-M-R II, VARIVAX (Merck), ZOSTAVAX, and PNEUMOVAX, but none of these vaccines have been administered and are not included in this adverse events. No product quality complaint (PQC) was involved. This is one of several reports received from the same reporter. Additional information has been requested.
Sex: U
Vaccine: PPV
Symptoms: Pain in extremity
Clinical narrative: This spontaneous report was received from a healthcare professional referring to a patient of unknown age and gender. Information about the patient's pertinent medical history, concurrent conditions and drug reactions/allergies was not reported. On 05-OCT-2015, the patient was vaccinated with PNEUMOVAX 23, (dose, lot # and expiration date were not provided). Concomitant medication was not reported. On 06-OCT-2015, reported as "within 24 hours", the patient experienced terrible pain in the arm after being vaccinated with PNEUMOVAX 23. The outcome of pain in extremity was reported as recovered on an unspecified date in October 2015, reported as "approximately one week after vaccination". The reporter did not assess the relatedness between pain in extremity and PNEUMOVAX 23. This is one of the several reports received from the same source. Additional information has been requested.
Sex: U
Vaccine: PPV
Symptoms: Pain in extremity
Clinical narrative: This spontaneous report was received from a healthcare professional referring to a patient of unknown age and gender. Information about the patient's pertinent medical history, concurrent conditions and drug reactions/allergies was not reported. On 20-OCT-2015, the patient was vaccinated with PNEUMOVAX 23, (dose, lot # and expiration date were not provided). Concomitant medication was not reported. On 21-OCT-2015, reported as "within 24 hours", the patient experienced terrible pain in the arm after being vaccinated with PNEUMOVAX 23. The outcome of pain in extremity was reported as recovered on an unspecified date in October 2015, reported as "approximately one week after vaccination". The reporter did not assess the relatedness between pain in extremity and PNEUMOVAX 23. This is one of the several reports received from the same source. Additional information has been requested.
Sex: U
Vaccine: PPV
Symptoms: Pain in extremity
Clinical narrative: This spontaneous report was received from a healthcare professional referring to a patient of unknown age and gender. Information about the patient's pertinent medical history, concurrent conditions and drug reactions/allergies was not reported. On 28-OCT-2015, the patient was vaccinated with PNEUMOVAX 23, (dose, lot # and expiration date were not provided).  Concomitant medication was not reported. On 29-OCT-2015, reported as "within 24 hours", the patient experienced terrible pain in the arm after being vaccinated with PNEUMOVAX 23. The outcome of pain in extremity was reported as recovered on an unspecified date in November 2015, reported as "approximately one week after vaccination". The reporter did not assess the relatedness between pain in extremity and PNEUMOVAX 23. This is one of the several reports received from the same source. Additional information has been requested.
Sex: U
Vaccine: PPV
Symptoms: Pain in extremity
Clinical narrative: This spontaneous report was received from a healthcare professional referring to a patient of unknown age and gender. Information about the patient's pertinent medical history, concurrent conditions and drug reactions/allergies was not reported. On 01-OCT-2015, the patient was vaccinated with PNEUMOVAX 23, (dose, lot # and expiration date were not provided). Concomitant medication was not reported. On 02-OCT-2015, reported as "within 24 hours", the patient experienced terrible pain in the arm after being vaccinated with PNEUMOVAX 23. The outcome of pain in extremity was reported as recovered on an unspecified date in October 2015, reported as "approximately one week after vaccination". The reporter did not assess the relatedness between pain in extremity and PNEUMOVAX 23. This is one of the several reports received from the same source. Additional information has been requested.
Sex: U
Vaccine: VARCEL
Symptoms: Expired product administered, No adverse event
Clinical narrative: This spontaneous report was received from a registered nurse referring to a patient of unknown age and gender. The patient's medical history and concurrent condition were not reported. On 07-DEC-2015, the patient was vaccinated with a properly stored but expired dose of VARIVAX (Merck) (lot # J013066; expiration date 16-OCT-2015) 0.5 ml, subcutaneous. Concomitant medication was not reported. No adverse reactions reported. There was no product quality complaint (PQC) involved. Additional information has been requested.
Sex: U
Vaccine: VARZOS
Symptoms: Immediate post-injection reaction, Injection site erythema, Injection site pain, Injection site pruritus
Clinical narrative: This spontaneous report was received from a pharmacist concerning to a patient of unknown age and gender. The patient's medical history and concurrent conditions were not reported. On 04-JAN-2016, also reported as 05-JAN-2016, the patient was vaccinated with ZOSTAVAX subcutaneous, 0.65 ml, once. No concomitant medications were reported. On 04-JAN-2016, reported as right away, the patient experienced soreness, itchiness, redness at injection site. The patient used a OTC pain relief product (unspecified) as treatment. The patient sought medical attention by visiting the pharmacy. The outcome of pain, injection site erythema and pruritus was reported as not recovered. Additional information is not expected as no consent to contact the HCP was informed.
Age: 46.0
Sex: M
Vaccine: VARCEL
Symptoms: Seroconversion test negative
Clinical narrative: This spontaneous report was received from a registered nurse referring to a 46 year old male patient. The patient's concurrent conditions included multiple sclerosis, erectile dysfunction and arthritis. The patient had no drug allergies or reactions. On 17-AUG-2015, the patient was vaccinated with the first dose of (Oka/Merck) VARIVAX, (dosage, route, lot number and expiration date were not provided). On 30-SEP-2015, patient had titers drawn which exhibited that the patient did not seroconvert (seroconversion test negative). On 05-NOV-2015, the patient was administered with a second dose of (Oka/Merck) VARIVAX (dosage, route, lot number K026387, expiration date 15-DEC-2016) and patient was tested again for titer on an unspecified recent date. Titers exhibited that the patient did not seroconvert (seroconversion test negative). Concomitant therapies included TYLENOL, amitriptyline hydrochloride, CIALIS and RAPAFLO. It was unknown if the patient finally seroconvert. Additional information has been requested.
Sex: U
Vaccine: PPV
Symptoms: Pain in extremity
Clinical narrative: This spontaneous report was received from a healthcare professional referring to a patient of unknown age and gender. Information about the patient's pertinent medical history, concurrent conditions and drug reactions/allergies was not reported. On 17-NOV-2015, the patient was vaccinated with PNEUMOVAX 23, (dose, lot # and expiration date were not provided). Concomitant medication was not reported. On 18-NOV-2015, reported as "within 24 hours", the patient experienced terrible pain in the arm after being vaccinated with PNEUMOVAX 23. The outcome of pain in extremity was reported as recovered on an unspecified date in November 2015, reported as "approximately one week after vaccination". The reporter did not assess the relatedness between pain in extremity and PNEUMOVAX 23. This is one of the several reports received from the same source. Additional information has been requested.
Sex: U
Vaccine: PPV
Symptoms: Pain in extremity
Clinical narrative: This spontaneous report was received from a healthcare professional referring to a patient of unknown age and gender. Information about the patient's pertinent medical history, concurrent conditions and drug reactions/allergies was not reported. On 19-OCT-2015, the patient was vaccinated with PNEUMOVAX 23, (dose, lot # and expiration date were not provided). Concomitant medication was not reported. On 20-OCT-2015, reported as "within 24 hours", the patient experienced terrible pain in the arm after being vaccinated with PNEUMOVAX 23. The outcome of pain in extremity was reported as recovered on an unspecified in October 2015, reported as "approximately one week after vaccination". The reporter did not assess the relatedness between pain in extremity and PNEUMOVAX 23. This is one of the several reports received from the same source. Additional information has been requested.
Sex: U
Vaccine: PPV
Symptoms: Pain in extremity
Clinical narrative: This spontaneous report was received from a healthcare professional referring to a patient of unknown age and gender. Information about the patient's pertinent medical history, concurrent conditions and drug reactions/allergies was not reported. On 27-OCT-2015, the patient was vaccinated with PNEUMOVAX 23, (dose, lot # and expiration date were not provided). Concomitant medication was not reported. On 28-OCT-2015, reported as "within 24 hours", the patient experienced terrible pain in the arm after being vaccinated with PNEUMOVAX 23. The outcome of pain in extremity was reported as recovered on an unspecified date in November 2015, reported as "approximately one week after vaccination". The reporter did not assess the relatedness between pain in extremity and PNEUMOVAX 23. This is one of the several reports received from the same source. Additional information has been requested.
Sex: U
Vaccine: PPV
Symptoms: Pain in extremity
Clinical narrative: This spontaneous report was received from a healthcare professional referring to a patient of unknown age and gender. Information about the patient's pertinent medical history, concurrent conditions and drug reactions/allergies was not reported. On 08-OCT-2015, the patient was vaccinated with PNEUMOVAX 23, (dose, lot # and expiration date were not provided). Concomitant medication was not reported. On 09-OCT-2015, reported as "within 24 hours", the patient experienced terrible pain in the arm after being vaccinated with PNEUMOVAX 23. The outcome of pain in extremity was reported as recovered on an unspecified date in October 2015, reported as "approximately one week after vaccination". The reporter did not assess the relatedness between pain in extremity and PNEUMOVAX 23. This is one of the several reports received from the same source. Additional information has been requested.
Sex: U
Vaccine: MENB
Symptoms: Pain
Clinical narrative: This case was reported by a nurse via sales rep and described the occurrence of pain in a patient who received BEXSERO. On an unknown date, the patient received BEXSERO at an unknown dose. On an unknown date, 7 days after receiving BEXSERO, the patient experienced pain. On an unknown date, the outcome of the pain was unknown. It was unknown if the reporter considered the pain to be related to BEXSERO. Additional details were received as follows: The patient experienced significant soreness and pain. This case has been linked with case US2016002739, reported by the same reporter.
Sex: F
Vaccine: HEPA, HPV4, MEN, VARCEL
Symptoms: Exposure during pregnancy, No adverse event, Pregnancy test positive, Pregnancy test urine positive, Ultrasound antenatal screen normal
Clinical narrative: Case number PHHY2015US100304, is an initial spontaneous report from the Vaccine Adverse Event Reporting System (VAERS, reference number: 575734) website on 11 Aug 2015. This report refers to a female pregnant patient of an unknown age. Concurrent condition included allergy to amoxicillin and with no pertinent medical history. No other concomitant medications were reported. The patent was vaccinated with meningococcal polysaccharide vaccine (manufacturer and batch number unknown), VARIVAX (batch number: unknown, other manufacturer), GARDASIL (batch number: unknown, other manufacturer) and hepatitis A vaccine (manufacturer and batch number unknown) on 17 Mar 2015. It was reported that the patient was pregnant during these vaccination. The LMP and EDD were not known. The pregnancy outcome was pending. The patient's pregnancy was confirmed on 08 Apr 2015. Laboratory diagnostic studies included pregnancy test (urine and blood) and ultrasound scan. Case was assessed as non-serious. No adverse event was reported This case was identified with a wrong pregnancy outcome during checks: This prospective pregnancy case was ongoing.
Age: 18.0
Sex: F
Vaccine: MENB
Symptoms: Exposure during pregnancy, Pain in extremity
Clinical narrative: Case number PHEH2015US006239 is an initial spontaneous report from a nurse received on 30 Mar 2015. This report refers to a 18 year old female patient. She had her normal menstrual period on 18 Feb 2015. She was vaccinated with BEXSERO (batch number: 146101) intramuscularly on 24 Feb 2015. On the same date, after vaccination she experienced sore arm. On 30 Mar 2015, the nurse reported that the patient was currently pregnant and possibly 6 weeks pregnant (not confirmed). The patient did not believe that she was pregnant at the time of vaccination. The patient did not receive the second dose of BEXSERO at the time of reporting. The outcome, seriousness and causality of the event sore arm was not reported. This case was identified with a wrong pregnancy outcome during checks: This prospective pregnancy case was ongoing.
Sex: U
Vaccine: MENB
Symptoms: Pain
Clinical narrative: This case was reported by a nurse via sales rep and described the occurrence of pain in a patient who received BEXSERO. On an unknown date, the patient received BEXSERO at an unknown dose. On an unknown date, 7 days after receiving BEXSERO, the patient experienced pain. On an unknown date, the outcome of the pain was unknown. It was unknown if the reporter considered the pain to be related to BEXSERO. Additional details were received as follows: The patient experienced significant soreness and pain. This case has been linked with the case US2016002741, reported by the same reporter.
Sex: U
Vaccine: VARCEL
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: Information has been received from a health professional  referring to a patient of unknown age. On an unknown date, the patient was vaccinated with improperly stored VARIVAX (Merck) (lot # l020004, expiration date 02-FEB-2017, dose, route and lot number not provided). Temperature was minus 9.2 C and there was previous temperature excursion then call was placed because of a "data logger". No adverse events  were reported. There was no product quality issue (PQC) involved. This is one of several reports received from the same source. Additional information has been requested.
Sex: U
Vaccine: MMRV
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: Information has been received from a health professional referring to a patient of unknown age. On an unknown date, the patient was vaccinated with improperly stored PROQUAD (Merck) (lot # L025204, expiration date 07-JAN-2016, dose, route and lot number not provided). Temperature was minus 9.2 C and there was previous temperature excursion then call was placed because if a "data logger". No adverse events were reported. There was no product quality issue (PQC) involved. This is one of several reports received from the same source. Additional information has been requested.
Sex: U
Vaccine: HEP
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report received from a registered nurse refers to multiple unspecified patients of unknown demographics. No medical history was reported. On multiple unspecified dates, multiple unspecified patients were vaccinated with improperly stored RECOMBIVAX HB, dose, route and frequency: unknown) (Lot no: J010613; expiry date: 11-JUN-2016). No other concomitant therapy was reported. No adverse event was reported. The reporter also inquired about the stability of M-M-R II, VARIVAX, and PNEUMOVAX (Merck) single-dose vials, but none of these vaccines have been administered and are not included in this adverse events. No product quality complaint (PQC) was involved. This is one of several reports received from the same reporter. Additional information has been requested.
Sex: F
Vaccine: HPV4
Symptoms: Exposure during pregnancy, No adverse event
Clinical narrative: This spontaneous prospective pregnancy report has been received from a physician referring to a female patient of unknown age. On 29-DEC-2015, a dose of GARDASIL (lot # K016966, expiration date 10-MAY-2017) was inadvertently administered to a pregnant patient (dose and route unknown). The last menstrual period (LMP) was on 19-MAY-2015 per the 32 weeks gestation at the reporting time and estimated delivery date (EDD) was on 23-FEB-2016. The pregnancy outcome was unknown. No adverse effects had been reported. Additional information has been requested.
Age: 0.3
Sex: U
Vaccine: MMRV, VARCEL
Symptoms: Drug administered to patient of inappropriate age, Extra dose administered, No adverse event
Clinical narrative: This spontaneous report has been received from a pharmacist referring to a 4 month old patient unknown gender. The patient's medical history and concurrent conditions were not provided.  On an unknown date, the patient was vaccinated at the same time with a dose of VARIVAX (Merck) and PROQUAD (Merck) (doses, anatomical locations, lot numbers and expiration dates were not reported). Concomitant therapies were not provided. No adverse effects reported. Additional information has been requested.
Age: 52.0
Sex: F
Vaccine: PPV
Symptoms: Allergy to vaccine, Mass, Neck mass
Clinical narrative: Large mass on (L) clavical - started 1-2 days after PNEUMAX 23 shot that was given on 11-15-15. Still has mass on neck.
Age: 73.0
Sex: F
Vaccine: FLU3
Symptoms: Injected limb mobility decreased, Injection site injury, Injection site pain, Pain, X-ray limb
Clinical narrative: SIRVA - Throbbing pain from shoulder to elbow, mobility of left arm affected. Treatment - 2 doctor visits, Prednisone prescription, 4 physical therapy sessions, still ongoing weekly sessions.
Age: 59.0
Sex: M
Vaccine: VARZOS, VARZOS
Symptoms: Herpes virus infection, Rash
Clinical narrative: This spontaneous report was received from a registered nurse referring to her husband, a 60 year old male patient. The patient did not have pertinent medical history nor drug reactions/allergies. On 14-DEC-2015, the patient was vaccinated with ZOSTAVAX, subcutaneously, 0.65 ml, lot # L029485, (expiration date was not provided). Concomitant medication included unspecified multivitamin. The reporter stated that, on 04-JAN-2016, the patient experienced shingles rash. The patient sought medical attention at an urgent care on 06-JAN-2016. The physician at the urgent care prescribed an unspecified dose of acyclovir (manufacturer unknown) and prednisone (manufacturer unknown) for the treatment of shingles, on 06-JAN-2016. The reporter stated that the rash was getting worse and followed the dermatome, so it was diagnosed as shingles. No lab diagnostics studies were performed. At the time of reporting, the outcome of herpes zoster was reported as not recovered. The reporter did not assess the relatedness between the herpes zoster and ZOSTAVAX. Additional information has been requested.
Age: 59.0
Sex: M
Vaccine: VARZOS, VARZOS
Symptoms: Herpes zoster
Clinical narrative: This spontaneous report was received from a registered nurse referring to her husband, a 60 year old male patient. The patient did not have pertinent medical history nor drug reactions/allergies. On 14-DEC-2015, the patient was vaccinated with ZOSTAVAX, subcutaneously, 0.65 ml, lot # L029485, (expiration date was not provided). Concomitant medication included unspecified multivitamin. The reporter stated that, on 04-JAN-2016, the patient experienced shingles rash. The patient sought medical attention at an urgent care on 06-JAN-2016. The physician at the urgent care prescribed an unspecified dose of acyclovir (manufacturer unknown) and prednisone (manufacturer unknown) for the treatment of shingles, on 06-JAN-2016. The reporter stated that the rash was getting worse and followed the dermatome, so it was diagnosed as shingles. No lab diagnostics studies were performed. At the time of reporting, the outcome of herpes zoster was reported as not recovered. The reporter did not assess the relatedness between the herpes zoster and ZOSTAVAX. Additional information has been requested.
Age: 22.0
Sex: F
Vaccine: MMR, MMR, MMR
Symptoms: Dizziness, Dyspnoea, Exercise tolerance decreased, Heart rate increased, Local swelling
Clinical narrative: This spontaneous report was received from the patient's mother concerning her 23 years old daughter. The patient's concurrent conditions and medical history were not provided. On 15-JUN-2015, the patient was vaccinated with the first dose of M-M-R II (dose, route and anatomical location were not specified) (lot # L002242, expiration date unknown). On 24-JUL-2015, the patient was vaccinated with a second dose of M-M-R II (dose, route and anatomical location were not specified). There was no concomitant medication reported. On an unknown date in 2015, reported as a few days later the first dose of M-M-R II, the patient experienced "light headed" and was having difficulty breathing. Later, on an unspecified date in approximately 2015, the patient experienced inability to catch breath, her heart rates was spiking and she felt muscle spasm in her legs (both). The patient went to an unspecified Emergency Room (date not described) and her blood pressure was 165/100 (units unspecified). A computed tomography san of lungs was performed to check for blood clots but the results were negative, a biopsy on thyroid was also performed and the result was described as benign. Additionally, the reporter added that the patient was an avid runner prior to vaccine, since the vaccine she has not been able to run and has diminished physical activity. The patient has to lay flat in a recliner. The patient also experienced sensitivity to loud music or bright lights. Patient experienced nausea and was heat intolerant. The patient breaks out in a hive looking rash when she takes a shower or uses any heat. Also she experienced severe pain in her face, behind her eyes, in her teeth and gums. Reporter stated that her daughter was unable to lay flat and has not been able to work out due to extreme fatigue. The patient was not hospitalized. At the time of this report, the outcome of exercise tolerance decreased, decreased activity, fatigue, heart rate abnormal, muscle spasm, blood pressure increased, hyperacusis, photophobia, temperature intolerance, facial pain, eye pain, gingival pain, toothache, movement disorder, urticarial thermal, dyspnea, dizziness and nausea was unknown. Additional information has been requested.
Age: 22.0
Sex: F
Vaccine: MMR, MMR, MMR
Symptoms: Migraine, Muscle spasms, Nausea, Rash, Swelling face
Clinical narrative: This spontaneous report was received from the patient's mother concerning her 23 years old daughter. The patient's concurrent conditions and medical history were not provided. On 15-JUN-2015, the patient was vaccinated with the first dose of M-M-R II (dose, route and anatomical location were not specified) (lot # L002242, expiration date unknown). On 24-JUL-2015, the patient was vaccinated with a second dose of M-M-R II (dose, route and anatomical location were not specified). There was no concomitant medication reported. On an unknown date in 2015, reported as a few days later the first dose of M-M-R II, the patient experienced "light headed" and was having difficulty breathing. Later, on an unspecified date in approximately 2015, the patient experienced inability to catch breath, her heart rates was spiking and she felt muscle spasm in her legs (both). The patient went to an unspecified Emergency Room (date not described) and her blood pressure was 165/100 (units unspecified). A computed tomography san of lungs was performed to check for blood clots but the results were negative, a biopsy on thyroid was also performed and the result was described as benign. Additionally, the reporter added that the patient was an avid runner prior to vaccine, since the vaccine she has not been able to run and has diminished physical activity. The patient has to lay flat in a recliner. The patient also experienced sensitivity to loud music or bright lights. Patient experienced nausea and was heat intolerant. The patient breaks out in a hive looking rash when she takes a shower or uses any heat. Also she experienced severe pain in her face, behind her eyes, in her teeth and gums. Reporter stated that her daughter was unable to lay flat and has not been able to work out due to extreme fatigue. The patient was not hospitalized. At the time of this report, the outcome of exercise tolerance decreased, decreased activity, fatigue, heart rate abnormal, muscle spasm, blood pressure increased, hyperacusis, photophobia, temperature intolerance, facial pain, eye pain, gingival pain, toothache, movement disorder, urticarial thermal, dyspnea, dizziness and nausea was unknown. Additional information has been requested.
Age: 22.0
Sex: F
Vaccine: MMR, MMR, MMR
Symptoms: Temperature intolerance
Clinical narrative: This spontaneous report was received from the patient's mother concerning her 23 years old daughter. The patient's concurrent conditions and medical history were not provided. On 15-JUN-2015, the patient was vaccinated with the first dose of M-M-R II (dose, route and anatomical location were not specified) (lot # L002242, expiration date unknown). On 24-JUL-2015, the patient was vaccinated with a second dose of M-M-R II (dose, route and anatomical location were not specified). There was no concomitant medication reported. On an unknown date in 2015, reported as a few days later the first dose of M-M-R II, the patient experienced "light headed" and was having difficulty breathing. Later, on an unspecified date in approximately 2015, the patient experienced inability to catch breath, her heart rates was spiking and she felt muscle spasm in her legs (both). The patient went to an unspecified Emergency Room (date not described) and her blood pressure was 165/100 (units unspecified). A computed tomography san of lungs was performed to check for blood clots but the results were negative, a biopsy on thyroid was also performed and the result was described as benign. Additionally, the reporter added that the patient was an avid runner prior to vaccine, since the vaccine she has not been able to run and has diminished physical activity. The patient has to lay flat in a recliner. The patient also experienced sensitivity to loud music or bright lights. Patient experienced nausea and was heat intolerant. The patient breaks out in a hive looking rash when she takes a shower or uses any heat. Also she experienced severe pain in her face, behind her eyes, in her teeth and gums. Reporter stated that her daughter was unable to lay flat and has not been able to work out due to extreme fatigue. The patient was not hospitalized. At the time of this report, the outcome of exercise tolerance decreased, decreased activity, fatigue, heart rate abnormal, muscle spasm, blood pressure increased, hyperacusis, photophobia, temperature intolerance, facial pain, eye pain, gingival pain, toothache, movement disorder, urticarial thermal, dyspnea, dizziness and nausea was unknown. Additional information has been requested.
Age: 22.0
Sex: F
Vaccine: MMR, MMR, MMR
Symptoms: Activities of daily living impaired, Biopsy thyroid gland normal, Computerised tomogram thorax normal, Decreased activity, Dizziness
Clinical narrative: This spontaneous report was received from the patient's mother concerning her 23 years old daughter. The patient's concurrent conditions and medical history were not provided. On 15-JUN-2015, the patient was vaccinated with the first dose of M-M-R II (dose, route and anatomical location were not specified) (lot # L002242, expiration date unknown). On 24-JUL-2015, the patient was vaccinated with a second dose of M-M-R II (dose, route and anatomical location were not specified). There was no concomitant medication reported. On an unknown date in 2015, reported as a few days later the first dose of M-M-R II, the patient experienced "light headed" and was having difficulty breathing. Later, on an unspecified date in approximately 2015, the patient experienced inability to catch breath, her heart rates was spiking and she felt muscle spasm in her legs (both). The patient went to an unspecified Emergency Room (date not described) and her blood pressure was 165/100 (units unspecified). A computed tomography san of lungs was performed to check for blood clots but the results were negative, a biopsy on thyroid was also performed and the result was described as benign. Additionally, the reporter added that the patient was an avid runner prior to vaccine, since the vaccine she has not been able to run and has diminished physical activity. The patient has to lay flat in a recliner. The patient also experienced sensitivity to loud music or bright lights. Patient experienced nausea and was heat intolerant. The patient breaks out in a hive looking rash when she takes a shower or uses any heat. Also she experienced severe pain in her face, behind her eyes, in her teeth and gums. Reporter stated that her daughter was unable to lay flat and has not been able to work out due to extreme fatigue. The patient was not hospitalized. At the time of this report, the outcome of exercise tolerance decreased, decreased activity, fatigue, heart rate abnormal, muscle spasm, blood pressure increased, hyperacusis, photophobia, temperature intolerance, facial pain, eye pain, gingival pain, toothache, movement disorder, urticarial thermal, dyspnea, dizziness and nausea was unknown. Additional information has been requested.
Age: 22.0
Sex: F
Vaccine: MMR, MMR, MMR
Symptoms: Dyspnoea, Exercise tolerance decreased, Eye pain, Facial pain, Fatigue
Clinical narrative: This spontaneous report was received from the patient's mother concerning her 23 years old daughter. The patient's concurrent conditions and medical history were not provided. On 15-JUN-2015, the patient was vaccinated with the first dose of M-M-R II (dose, route and anatomical location were not specified) (lot # L002242, expiration date unknown). On 24-JUL-2015, the patient was vaccinated with a second dose of M-M-R II (dose, route and anatomical location were not specified). There was no concomitant medication reported. On an unknown date in 2015, reported as a few days later the first dose of M-M-R II, the patient experienced "light headed" and was having difficulty breathing. Later, on an unspecified date in approximately 2015, the patient experienced inability to catch breath, her heart rates was spiking and she felt muscle spasm in her legs (both). The patient went to an unspecified Emergency Room (date not described) and her blood pressure was 165/100 (units unspecified). A computed tomography san of lungs was performed to check for blood clots but the results were negative, a biopsy on thyroid was also performed and the result was described as benign. Additionally, the reporter added that the patient was an avid runner prior to vaccine, since the vaccine she has not been able to run and has diminished physical activity. The patient has to lay flat in a recliner. The patient also experienced sensitivity to loud music or bright lights. Patient experienced nausea and was heat intolerant. The patient breaks out in a hive looking rash when she takes a shower or uses any heat. Also she experienced severe pain in her face, behind her eyes, in her teeth and gums. Reporter stated that her daughter was unable to lay flat and has not been able to work out due to extreme fatigue. The patient was not hospitalized. At the time of this report, the outcome of exercise tolerance decreased, decreased activity, fatigue, heart rate abnormal, muscle spasm, blood pressure increased, hyperacusis, photophobia, temperature intolerance, facial pain, eye pain, gingival pain, toothache, movement disorder, urticarial thermal, dyspnea, dizziness and nausea was unknown. Additional information has been requested.
Age: 22.0
Sex: F
Vaccine: MMR, MMR, MMR
Symptoms: Gingival pain, Heart rate increased, Hyperacusis, Muscle spasms, Nausea
Clinical narrative: This spontaneous report was received from the patient's mother concerning her 23 years old daughter. The patient's concurrent conditions and medical history were not provided. On 15-JUN-2015, the patient was vaccinated with the first dose of M-M-R II (dose, route and anatomical location were not specified) (lot # L002242, expiration date unknown). On 24-JUL-2015, the patient was vaccinated with a second dose of M-M-R II (dose, route and anatomical location were not specified). There was no concomitant medication reported. On an unknown date in 2015, reported as a few days later the first dose of M-M-R II, the patient experienced "light headed" and was having difficulty breathing. Later, on an unspecified date in approximately 2015, the patient experienced inability to catch breath, her heart rates was spiking and she felt muscle spasm in her legs (both). The patient went to an unspecified Emergency Room (date not described) and her blood pressure was 165/100 (units unspecified). A computed tomography san of lungs was performed to check for blood clots but the results were negative, a biopsy on thyroid was also performed and the result was described as benign. Additionally, the reporter added that the patient was an avid runner prior to vaccine, since the vaccine she has not been able to run and has diminished physical activity. The patient has to lay flat in a recliner. The patient also experienced sensitivity to loud music or bright lights. Patient experienced nausea and was heat intolerant. The patient breaks out in a hive looking rash when she takes a shower or uses any heat. Also she experienced severe pain in her face, behind her eyes, in her teeth and gums. Reporter stated that her daughter was unable to lay flat and has not been able to work out due to extreme fatigue. The patient was not hospitalized. At the time of this report, the outcome of exercise tolerance decreased, decreased activity, fatigue, heart rate abnormal, muscle spasm, blood pressure increased, hyperacusis, photophobia, temperature intolerance, facial pain, eye pain, gingival pain, toothache, movement disorder, urticarial thermal, dyspnea, dizziness and nausea was unknown. Additional information has been requested.
Age: 22.0
Sex: F
Vaccine: MMR, MMR, MMR
Symptoms: Photophobia, Temperature intolerance, Toothache, Urticaria
Clinical narrative: This spontaneous report was received from the patient's mother concerning her 23 years old daughter. The patient's concurrent conditions and medical history were not provided. On 15-JUN-2015, the patient was vaccinated with the first dose of M-M-R II (dose, route and anatomical location were not specified) (lot # L002242, expiration date unknown). On 24-JUL-2015, the patient was vaccinated with a second dose of M-M-R II (dose, route and anatomical location were not specified). There was no concomitant medication reported. On an unknown date in 2015, reported as a few days later the first dose of M-M-R II, the patient experienced "light headed" and was having difficulty breathing. Later, on an unspecified date in approximately 2015, the patient experienced inability to catch breath, her heart rates was spiking and she felt muscle spasm in her legs (both). The patient went to an unspecified Emergency Room (date not described) and her blood pressure was 165/100 (units unspecified). A computed tomography san of lungs was performed to check for blood clots but the results were negative, a biopsy on thyroid was also performed and the result was described as benign. Additionally, the reporter added that the patient was an avid runner prior to vaccine, since the vaccine she has not been able to run and has diminished physical activity. The patient has to lay flat in a recliner. The patient also experienced sensitivity to loud music or bright lights. Patient experienced nausea and was heat intolerant. The patient breaks out in a hive looking rash when she takes a shower or uses any heat. Also she experienced severe pain in her face, behind her eyes, in her teeth and gums. Reporter stated that her daughter was unable to lay flat and has not been able to work out due to extreme fatigue. The patient was not hospitalized. At the time of this report, the outcome of exercise tolerance decreased, decreased activity, fatigue, heart rate abnormal, muscle spasm, blood pressure increased, hyperacusis, photophobia, temperature intolerance, facial pain, eye pain, gingival pain, toothache, movement disorder, urticarial thermal, dyspnea, dizziness and nausea was unknown. Additional information has been requested.
Age: 22.0
Sex: F
Vaccine: MMR, MMR, MMR
Symptoms: Biopsy thyroid gland normal, Blood cortisol abnormal, Blood pressure fluctuation, Cardiac monitoring, Chest X-ray
Clinical narrative: This spontaneous report was received from the patient's mother concerning her 23 years old daughter. The patient's concurrent conditions and medical history were not provided. On 15-JUN-2015, the patient was vaccinated with the first dose of M-M-R II (dose, route and anatomical location were not specified) (lot # L002242, expiration date unknown). On 24-JUL-2015, the patient was vaccinated with a second dose of M-M-R II (dose, route and anatomical location were not specified). There was no concomitant medication reported. On an unknown date in 2015, reported as a few days later the first dose of M-M-R II, the patient experienced "light headed" and was having difficulty breathing. Later, on an unspecified date in approximately 2015, the patient experienced inability to catch breath, her heart rates was spiking and she felt muscle spasm in her legs (both). The patient went to an unspecified Emergency Room (date not described) and her blood pressure was 165/100 (units unspecified). A computed tomography san of lungs was performed to check for blood clots but the results were negative, a biopsy on thyroid was also performed and the result was described as benign. Additionally, the reporter added that the patient was an avid runner prior to vaccine, since the vaccine she has not been able to run and has diminished physical activity. The patient has to lay flat in a recliner. The patient also experienced sensitivity to loud music or bright lights. Patient experienced nausea and was heat intolerant. The patient breaks out in a hive looking rash when she takes a shower or uses any heat. Also she experienced severe pain in her face, behind her eyes, in her teeth and gums. Reporter stated that her daughter was unable to lay flat and has not been able to work out due to extreme fatigue. The patient was not hospitalized. At the time of this report, the outcome of exercise tolerance decreased, decreased activity, fatigue, heart rate abnormal, muscle spasm, blood pressure increased, hyperacusis, photophobia, temperature intolerance, facial pain, eye pain, gingival pain, toothache, movement disorder, urticarial thermal, dyspnea, dizziness and nausea was unknown. Additional information has been requested.
Age: 22.0
Sex: F
Vaccine: MMR, MMR, MMR
Symptoms: Chest pain, Computerised tomogram head normal, Computerised tomogram normal, Computerised tomogram thorax abnormal, Cough
Clinical narrative: This spontaneous report was received from the patient's mother concerning her 23 years old daughter. The patient's concurrent conditions and medical history were not provided. On 15-JUN-2015, the patient was vaccinated with the first dose of M-M-R II (dose, route and anatomical location were not specified) (lot # L002242, expiration date unknown). On 24-JUL-2015, the patient was vaccinated with a second dose of M-M-R II (dose, route and anatomical location were not specified). There was no concomitant medication reported. On an unknown date in 2015, reported as a few days later the first dose of M-M-R II, the patient experienced "light headed" and was having difficulty breathing. Later, on an unspecified date in approximately 2015, the patient experienced inability to catch breath, her heart rates was spiking and she felt muscle spasm in her legs (both). The patient went to an unspecified Emergency Room (date not described) and her blood pressure was 165/100 (units unspecified). A computed tomography san of lungs was performed to check for blood clots but the results were negative, a biopsy on thyroid was also performed and the result was described as benign. Additionally, the reporter added that the patient was an avid runner prior to vaccine, since the vaccine she has not been able to run and has diminished physical activity. The patient has to lay flat in a recliner. The patient also experienced sensitivity to loud music or bright lights. Patient experienced nausea and was heat intolerant. The patient breaks out in a hive looking rash when she takes a shower or uses any heat. Also she experienced severe pain in her face, behind her eyes, in her teeth and gums. Reporter stated that her daughter was unable to lay flat and has not been able to work out due to extreme fatigue. The patient was not hospitalized. At the time of this report, the outcome of exercise tolerance decreased, decreased activity, fatigue, heart rate abnormal, muscle spasm, blood pressure increased, hyperacusis, photophobia, temperature intolerance, facial pain, eye pain, gingival pain, toothache, movement disorder, urticarial thermal, dyspnea, dizziness and nausea was unknown. Additional information has been requested.
Age: 22.0
Sex: F
Vaccine: MMR, MMR, MMR
Symptoms: Dizziness, Dyspnoea, Echocardiogram normal, Exercise tolerance increased, Fatigue
Clinical narrative: This spontaneous report was received from the patient's mother concerning her 23 years old daughter. The patient's concurrent conditions and medical history were not provided. On 15-JUN-2015, the patient was vaccinated with the first dose of M-M-R II (dose, route and anatomical location were not specified) (lot # L002242, expiration date unknown). On 24-JUL-2015, the patient was vaccinated with a second dose of M-M-R II (dose, route and anatomical location were not specified). There was no concomitant medication reported. On an unknown date in 2015, reported as a few days later the first dose of M-M-R II, the patient experienced "light headed" and was having difficulty breathing. Later, on an unspecified date in approximately 2015, the patient experienced inability to catch breath, her heart rates was spiking and she felt muscle spasm in her legs (both). The patient went to an unspecified Emergency Room (date not described) and her blood pressure was 165/100 (units unspecified). A computed tomography san of lungs was performed to check for blood clots but the results were negative, a biopsy on thyroid was also performed and the result was described as benign. Additionally, the reporter added that the patient was an avid runner prior to vaccine, since the vaccine she has not been able to run and has diminished physical activity. The patient has to lay flat in a recliner. The patient also experienced sensitivity to loud music or bright lights. Patient experienced nausea and was heat intolerant. The patient breaks out in a hive looking rash when she takes a shower or uses any heat. Also she experienced severe pain in her face, behind her eyes, in her teeth and gums. Reporter stated that her daughter was unable to lay flat and has not been able to work out due to extreme fatigue. The patient was not hospitalized. At the time of this report, the outcome of exercise tolerance decreased, decreased activity, fatigue, heart rate abnormal, muscle spasm, blood pressure increased, hyperacusis, photophobia, temperature intolerance, facial pain, eye pain, gingival pain, toothache, movement disorder, urticarial thermal, dyspnea, dizziness and nausea was unknown. Additional information has been requested.